Clinical Trial Update: Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating prednisone, azathioprine, and N-acetylcysteine in idiopathic pulmonary fibrosis has completed. Results were posted on 2015-06-02.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Azathioprine (azathioprine)
• N-acetylcysteine (N-acetylcysteine)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Duke University | Conditions: Pulmonary Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2015-06-02